Variant report

Variant	nsv482065
Chromosome Location	chr20:23026271-23030301
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:20)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:20 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr20:23014536..23017577-chr20:23027797..23030031,3	MCF-7	breast:
2	chr20:23013867..23016399-chr20:23024007..23026850,4	MCF-7	breast:
3	chr20:23027878..23030071-chr20:23034323..23036508,3	MCF-7	breast:
4	chr20:23023433..23026354-chr20:23029463..23031147,2	K562	blood:
5	chr20:23029084..23031719-chr20:23329992..23332006,2	K562	blood:
6	chr20:23028945..23029562-chr20:23159594..23160287,2	MCF-7	breast:
7	chr20:23025358..23028275-chr20:23031819..23034490,2	K562	blood:
8	chr20:23021523..23024307-chr20:23024511..23026678,2	MCF-7	breast:
9	chr20:22902552..22904666-chr20:23025197..23027691,2	MCF-7	breast:
10	chr20:22981576..22983427-chr20:23027736..23029557,2	MCF-7	breast:
11	chr20:23020985..23023221-chr20:23027756..23029605,2	MCF-7	breast:
12	chr20:23017212..23020123-chr20:23028174..23031939,4	MCF-7	breast:
13	chr20:23025165..23029019-chr20:23031172..23033319,4	K562	blood:
14	chr20:23029838..23032400-chr20:23167323..23168960,2	MCF-7	breast:
15	chr20:22937256..22939082-chr20:23027729..23030001,2	MCF-7	breast:
16	chr20:22900035..22903023-chr20:23024141..23027571,3	MCF-7	breast:
17	chr20:23024367..23027840-chr20:23028206..23030938,4	MCF-7	breast:
18	chr20:23028682..23030342-chr20:23324777..23326574,2	MCF-7	breast:
19	chr20:23029557..23031432-chr20:23330980..23333181,2	MCF-7	breast:
20	chr20:22916739..22919251-chr20:23028353..23030114,2	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000234832	chromatin interactions
ENSG00000132671	chromatin interactions
ENSG00000178726	chromatin interactions
ENSG00000230387	chromatin interactions
ENSG00000234646	chromatin interactions
ENSG00000132661	chromatin interactions

Extended variants
information (count: 196 )
Associated
traits (count: 58 )

Variant overlapped rSNPs/rCNVs (count:196 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs3176126	chr20:23026271-23026272	Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs536093215	chr20:23026278-23026279	Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs372816835	chr20:23026285-23026286	Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs6113910	chr20:23026368-23026369	Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs534184183	chr20:23026391-23026392	Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs3176136	chr20:23026421-23026422	Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Active TSS Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs534957785	chr20:23026423-23026424	Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Active TSS Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs1962	chr20:23026496-23026497	Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Active TSS Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
9	rs570890550	chr20:23026504-23026505	Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Active TSS Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs191096584	chr20:23026584-23026585	Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Active TSS Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs557474793	chr20:23026594-23026595	Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Active TSS Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs3179769	chr20:23026634-23026635	Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Active TSS Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs113252822	chr20:23026644-23026645	Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Active TSS Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs3176135	chr20:23026651-23026652	Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Active TSS Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs551264425	chr20:23026679-23026680	Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Active TSS Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs542015016	chr20:23026704-23026705	Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Active TSS Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs371533901	chr20:23026774-23026775	Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Active TSS Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs561688432	chr20:23026789-23026790	Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Active TSS Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs572395082	chr20:23026790-23026791	Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Active TSS Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs183647515	chr20:23026852-23026853	Weak transcription Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs564360014	chr20:23026873-23026874	Weak transcription Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs3176124	chr20:23026945-23026946	Weak transcription Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs375737788	chr20:23026987-23026988	Weak transcription Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs6082989	chr20:23027043-23027044	Enhancers Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs551790737	chr20:23027112-23027113	Enhancers Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs543047467	chr20:23027138-23027139	Enhancers Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs563439109	chr20:23027143-23027144	Enhancers Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs528933728	chr20:23027145-23027146	Enhancers Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs549574979	chr20:23027175-23027176	Enhancers Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs143450327	chr20:23027243-23027244	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs528644986	chr20:23027247-23027248	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs551683637	chr20:23027351-23027352	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs150954754	chr20:23027373-23027374	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs534762196	chr20:23027403-23027404	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs3176123	chr20:23027413-23027414	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
36	rs557031106	chr20:23027470-23027471	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs567754337	chr20:23027549-23027550	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs536323252	chr20:23027580-23027581	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs555554659	chr20:23027595-23027596	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs1042580	chr20:23027621-23027622	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs539785413	chr20:23027639-23027640	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs73611750	chr20:23027655-23027656	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs577992030	chr20:23027671-23027672	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs112351065	chr20:23027679-23027680	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs543416665	chr20:23027697-23027698	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs542206777	chr20:23027715-23027716	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs140801073	chr20:23027717-23027718	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs35315479	chr20:23027820-23027821	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs560822407	chr20:23027835-23027836	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs542392545	chr20:23027844-23027845	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:58)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	16272173	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	19627613	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Colorectal cancer	19359472	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Central neurocytomas	17123091	CNVD
Colorectal cancer	16272173	CNVD
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Colorectal cancer	21645411	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Autism	22495311	CNVD
Renal cell carcinoma	18765545	CNVD
Alagille syndrome	17576883	CNVD
Anaplastic large cell lymphoma	18179710	CNVD
Prostate cancer	18632612	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Cancer	21183584	CNVD
Myxofibrosarcoma	16751306	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Breast cancer	16608533	CNVD
Cancer	20164919	CNVD
Bladder cancer	21909424	CNVD
Esophageal cancer	21851588	CNVD
Breast cancer	17133270	CNVD
Thrombophilia	17576883	CNVD
Myelofibrosis	22110671	CNVD
Mental retardation	21062444	CNVD
Hepatocellular carcinoma	22174799	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Chordoma	18071362	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Osteosarcoma	21215367	CNVD

Chromatin state (count:407 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr20:23016200-23028200	Weak transcription	Aorta	Aorta
2	chr20:23020800-23026400	Weak transcription	A549	lung
3	chr20:23021000-23026800	Weak transcription	HMEC	breast
4	chr20:23021600-23026400	Weak transcription	Lung	lung
5	chr20:23021600-23027000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
6	chr20:23024000-23026400	Weak transcription	Primary monocytes fromperipheralblood	blood
7	chr20:23024200-23028200	Weak transcription	Pancreas	Pancrea
8	chr20:23024400-23026400	Weak transcription	Esophagus	oesophagus
9	chr20:23024600-23031400	Weak transcription	K562	blood
10	chr20:23024800-23026600	Weak transcription	Stomach Mucosa	stomach
11	chr20:23024800-23027000	Weak transcription	Gastric	stomach
12	chr20:23025200-23026600	Enhancers	Placenta Amnion	Placenta Amnion
13	chr20:23025400-23027000	Bivalent Enhancer	Primary neutrophils fromperipheralblood	blood
14	chr20:23025600-23026400	Enhancers	Fetal Muscle Leg	muscle
15	chr20:23025600-23026400	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
16	chr20:23025800-23026800	Weak transcription	Placenta	Placenta
17	chr20:23025800-23026800	Enhancers	Skeletal Muscle Female	skeletal muscle
18	chr20:23025800-23027000	Active TSS	Right Atrium	heart
19	chr20:23025800-23028000	Weak transcription	Spleen	Spleen
20	chr20:23025800-23028400	Transcr. at gene 5' and 3'	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
21	chr20:23026000-23026400	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
22	chr20:23026000-23026600	Enhancers	Skeletal Muscle Male	skeletal muscle
23	chr20:23026000-23027000	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
24	chr20:23026000-23032400	Active TSS	Pancreatic Islets	Pancreatic Islet
25	chr20:23026200-23026600	Active TSS	Duodenum Smooth Muscle	Duodenum
26	chr20:23026200-23026800	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
27	chr20:23026200-23026800	Active TSS	HSMMtube	muscle
28	chr20:23026200-23027000	Active TSS	Psoas Muscle	Psoas
29	chr20:23026200-23027200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
30	chr20:23026200-23027200	Enhancers	Breast Myoepithelial Primary Cells	Breast
31	chr20:23026400-23026600	Flanking Active TSS	Adipose Nuclei	Adipose
32	chr20:23026400-23026600	Enhancers	Esophagus	oesophagus
33	chr20:23026400-23026600	Active TSS	A549	lung
34	chr20:23026400-23026800	Enhancers	HSMM	muscle
35	chr20:23026400-23026800	Bivalent/Poised TSS	Monocytes-CD14+_RO01746	blood
36	chr20:23026400-23026800	Enhancers	NHDF-Ad	bronchial
37	chr20:23026400-23027000	Enhancers	Primary monocytes fromperipheralblood	blood
38	chr20:23026400-23027000	Bivalent Enhancer	Fetal Lung	lung
39	chr20:23026400-23027000	Active TSS	Lung	lung
40	chr20:23026400-23027600	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
41	chr20:23026400-23027600	Bivalent Enhancer	Fetal Muscle Leg	muscle
42	chr20:23026400-23028400	Bivalent/Poised TSS	Stomach Smooth Muscle	stomach
43	chr20:23026600-23027000	Weak transcription	Esophagus	oesophagus
44	chr20:23026600-23027000	Active TSS	Placenta Amnion	Placenta Amnion
45	chr20:23026600-23027400	Flanking Active TSS	A549	lung
46	chr20:23026600-23027600	Active TSS	Adipose Nuclei	Adipose
47	chr20:23026600-23028200	Enhancers	Stomach Mucosa	stomach
48	chr20:23026600-23029600	Bivalent/Poised TSS	Duodenum Smooth Muscle	Duodenum
49	chr20:23026600-23030400	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
50	chr20:23026800-23027000	Flanking Active TSS	HSMMtube	muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links